Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Long-Term Debt Repayments (2016 - 2025)

Haemonetics (HAE) has 16 years of Long-Term Debt Repayments data on record, last reported at $1.6 million in Q4 2025.

  • For Q4 2025, Long-Term Debt Repayments rose 103.33% year-over-year to $1.6 million; the TTM value through Dec 2025 reached $6.3 million, down 5.65%, while the annual FY2025 figure was $4.7 million, 61.73% down from the prior year.
  • Long-Term Debt Repayments reached $1.6 million in Q4 2025 per HAE's latest filing, roughly flat from $1.6 million in the prior quarter.
  • Across five years, Long-Term Debt Repayments topped out at $48.4 million in Q3 2024 and bottomed at -$46.9 million in Q4 2024.
  • Average Long-Term Debt Repayments over 5 years is $2.9 million, with a median of $2.6 million recorded in 2022.
  • Peak YoY movement for Long-Term Debt Repayments: tumbled 1022.86% in 2023, then skyrocketed 2867.83% in 2024.
  • A 5-year view of Long-Term Debt Repayments shows it stood at $4.4 million in 2021, then surged by 902.86% to $43.9 million in 2022, then tumbled by 80.06% to $8.8 million in 2023, then plummeted by 635.71% to -$46.9 million in 2024, then surged by 103.33% to $1.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Long-Term Debt Repayments were $1.6 million in Q4 2025, $1.6 million in Q3 2025, and $1.6 million in Q2 2025.